Samah AlQahtani

ORCID: 0000-0002-5051-6756
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sepsis Diagnosis and Treatment
  • Intensive Care Unit Cognitive Disorders
  • Long-Term Effects of COVID-19
  • COVID-19 Clinical Research Studies
  • Nutrition and Health in Aging
  • Clinical Nutrition and Gastroenterology
  • Respiratory Support and Mechanisms
  • Electrolyte and hormonal disorders
  • Bone health and treatments
  • Peripheral Neuropathies and Disorders
  • Frailty in Older Adults
  • Intestinal Malrotation and Obstruction Disorders
  • Diabetes Management and Education
  • Antibiotics Pharmacokinetics and Efficacy
  • Congenital Diaphragmatic Hernia Studies
  • Bone Tumor Diagnosis and Treatments
  • Pharmaceutical Economics and Policy
  • Renal function and acid-base balance
  • Innovations in Medical Education
  • Hereditary Neurological Disorders
  • Health and Medical Research Impacts
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Oral and Maxillofacial Pathology
  • Diabetes Treatment and Management
  • Tuberculosis Research and Epidemiology

King Saud bin Abdulaziz University for Health Sciences
2018-2024

King Abdulaziz Medical City
2022-2024

National Guard Health Affairs
2022-2024

King Abdullah International Medical Research Center
2022-2024

Security Forces Hospital
2019-2022

Hospital for Sick Children
2019

Yaseen M. Arabi Hasan M. Al‐Dorzi Omar Aldibaasi Musharaf Sadat Jesna Jose and 95 more Dina Muharib Haifa Algethamy Abdulrahman Al‐Fares Fahad Al-Hameed Ahmed Mady Ayman Kharaba Ali Al Bshabshe Khalid Maghrabi Khalid Alghamdi Ghulam Rasool Adnan Alghamdi Ghaleb A. Almekhlafi Jamal Chalabi Haifaa Ibrahim AlHumedi Maram Sakkijha Norah Khalid Alamrey Amjad Sami Alaskar Rabeah Hamad Alhutail Kaouthar Sifaoui Rakan Alqahtani Ahmad S Qureshi Mohammed Moneer Hejazi Hatim Arishi Samah AlQahtani Amro Mohamed Ghazi Saleh T. Baaziz Abeer Othman Azhar Sara Fahad Alabbas Mohammed AlAqeely Ohoud AlOrabi Aliaa Al-Mutawa Maha Alotaibi Madiha Fawazy Elghannam Mohammed Almaani Sarah Buabbas Wadiah Alawi M. Al-Filfil Mohammed Alshahrani Joel Starkopf Jean‐Charles Preiser Anders Perner Jumana Hani AlMubarak Wafa Mansoor Hazem Talal Albrahim Abdulaziz Al‐Dawood Amal Al-Matroud Brintha Naidu Vicki Burrow Salha Al Zayer Haseena Banu Khan Afonso Varela Hatim Arishi Mohammed Moneer Hejazi Mohamed Ali Alodat Rayan Alshayeh AbdulRehman AlHarthi Naif Al Qahtani Yasmeen Ayed AlHejiely Mada Muzhir AlZahrani Mohammed Lhmdi Nouf AlBakhiet Katrina Baguisa Huda Mhawisg Haifa Alghethamy Liyakat Khan Moataz Gabr Nuzhat Shehla Ohoud AlOrabi Raghad Malabari Kholoud Shobragi Shaymaa Asaas Madiha Fawazy Elghannam Beverly Bcuizon Bander AlAnezi Christine Joy Anaud Munir Mustafa Aldammad Yahia Otaif Osama Hakami Arwa AlHusseini Shahinaz Bashir Lama Hefni Samahar Alamoudi Milyn L. Ansing Sawsan Albalawi Manar Alahmadi Mohammed Humaid Alhumaid Samar Talal Nouri Rozeena Huma K. Mohammed Farhan Mohamed A. Hussein Olfa Baji Abdulrehman Alerw Khloud Johani Monera AlEnezi Ismail Boudrar Rabiah Atiq

The optimal amount and timing of protein intake in critically ill patients are unknown. REPLENISH (Replacing Protein via Enteral Nutrition a Stepwise Approach Critically Ill Patients) trial evaluates whether supplemental enteral added to standard nutrition achieve high given from ICU day five until discharge or 90 as compared no moderate would reduce all-cause 90-day mortality adult mechanically ventilated patients.

10.1186/s13063-024-08105-w article EN cc-by Trials 2024-05-02

Abstract Background This study assessed the mobility levels among critically ill patients and association of early with incident proximal lower-limb deep-vein thrombosis 90-day mortality. Methods was a post hoc analysis multicenter PREVENT trial, which evaluated adjunctive intermittent pneumatic compression in receiving pharmacologic thromboprophylaxis an expected ICU stay ≥ 72 h found no effect on primary outcome thrombosis. Mobility were documented daily up to day 28 using tool 8-point...

10.1186/s13054-023-04333-9 article EN cc-by Critical Care 2023-03-03
Yaseen M. Arabi Hasan M. Al‐Dorzi Musharaf Sadat Dina Muharib Haifa Algethamy and 89 more Fahad Al-Hameed Ahmed Mady Adnan Alghamdi Ghaleb A. Almekhlafi Abdulrahman Al‐Fares Ayman Kharaba Ali Al Bshabshe Khalid Maghrabi Khalid Al Ghamdi Ghulam Rasool Jamal Chalabi Haifaa Ibrahim AlHumedi Maram Sakkijha Norah Khalid Alamrey Rabeah Hamad Alhutail Kaouthar Sifaoui Mohammed Almaani Rakan Alqahtani Ahmad S Qureshi Mohammed Moneer Hejazi Hatim Arishi Samah AlQahtani Amro Mohamed Ghazi Saleh T. Baaziz Abeer Othman Azhar Sara Fahad Alabbas Mohammed AlAqeely Ohoud AlOrabi Aliaa Al-Mutawa Maha Alotaibi Omar Aldibaasi Jesna Jose Joel Starkopf Jean‐Charles Preiser Anders Perner Abdulaziz Al‐Dawood Amal Al-Matroud Brintha Naidu Vicki Burrow Salha Al Zayer Haseena Banu Khan Afonso Varela Mohamed Ali Alodat Rayan Alshayeh AbdulRehman AlHarthi Naif Al Qahtani Yasmeen Ayed AlHejiely Mada Muzhir AlZahrani Mohammed Lhmdi Katrina Baguisa Huda Mhawisg Liyakat Khan Moataz Gabr Nuzhat Shehla Madiha Fawazy Elghannam Beverly Bcuizon Bander AlAnezi Christine Joy Anaud Sawsan Albalawi Manar Alahmadi Mohammed Humaid Alhumaid Samar Talal Nouri Rozeena Huma K. Mohammed Farhan Samahar Alamoudi Milyn L. Ansing Raghad Malabari Kholoud Shobragi Shaymaa Asaas Ahmed Quadri Khalid Idrees Arwa AlHusseini Shahinaz Bashir Mohamed A. Hussein Olfa Baji Abdulrehman Alerw Khloud Johani Monera AlEnezi Ismail Boudrar Rabiah Atiq Maali Junid Maram Yusef Mona Bin Mabkoot Munir Mustafa Aldammad Yahia Otaif Osama Hakami Mariam Ehab Kenawy Dalal Ali Alkhamees Tasneem Abdullah Behbehani

Abstract Background Protein intake is recommended in critically ill patients to mitigate the negative effects of critical illness-induced catabolism and muscle wasting. However, optimal dose enteral protein remains unknown. We hypothesize that supplemental (1.2 g/kg/day) added standard nutrition formula achieve high amount (range 2–2.4 given from ICU day 5 until discharge or 90 as compared no moderate (0.8–1.2 would reduce all-cause 90-day mortality adult mechanically ventilated patients....

10.1186/s13063-023-07507-6 article EN cc-by Trials 2023-07-30

Objective To evaluate characteristics and outcomes in critically ill patients with Guillain–Barré syndrome (GBS). Methods Consecutive adults GBS who required intensive care unit (ICU) admission at a tertiary-care hospital between 1999 2020 were enrolled into this retrospective cohort study. Demographics, clinical data patient compared did or not receive mechanical ventilation (MV). Results During the study period, number of ICU admissions gradually rose from approximately 900 to 3000...

10.1177/03000605241306655 article EN cc-by-nc Journal of International Medical Research 2024-12-01

MRI was performed, which showed a clinical finding consistent with FD expansion of the base skull

10.19080/gjo.2018.15.555931 article EN Global Journal of Otolaryngology 2018-06-14

Background: Diabetes mellitus (DM) is a well-established risk factor for cardiovascular diseases (CVD), including stroke. As the global prevalence of diabetes continues to rise, so does its contribution increasing incidence stroke, particularly ischemic strokes. The coexistence with other stroke factors, such as hypertension, dyslipidemia, and obesity, significantly amplifies risk. management post-stroke complex, inadequate control blood glucose increases recurrent strokes worsens patient...

10.53730/ijhs.v1ns1.15342 article EN International Journal of Health Sciences 2017-01-15

A limited number of novel genes have been recently identified as a cause for pediatric chronic intestinal pseudo-obstruction (CIPO). We describe case child with new variant ACTG2 mutation causing bladder and dysmotility. CASE REPORT Case description: 3-year-old male patient history severe constipation starting at 1 year age was referred to the care failure program Hospital Sick Children further diagnostic therapeutic work-up. At 2 years he not responding laxatives required manual...

10.1093/jcag/gwz006.137 article EN cc-by-nc-nd Journal of the Canadian Association of Gastroenterology 2019-03-01

Abstract Background Protein intake is recommended in critically ill patients to mitigate the negative effects of critical illness-induced catabolism and muscle wasting. However, optimal dose enteral protein remains unknown. We hypothesize that supplemental (1.2 g/kg/day) added standard nutrition formula achieve high amount (range 2-2.4 given from ICU day 5 until discharge or 90 as compared no moderate (0.8-1.2 would reduce all-cause 90-day mortality adult mechanically ventilated patients....

10.1101/2022.11.10.22282161 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2022-11-11
Coming Soon ...